| Literature DB >> 23065757 |
Wei Zhang1, Xuelian Wang, Xiaoping Xia, Xia Liu, Shanshan Suo, Jing Guo, Min Li, Wenqiang Cao, Zhijian Cai, Zhaoyuan Hui, Malayannan Subramaniam, Thomas C Spelsberg, Jianli Wang, Lie Wang.
Abstract
Bone marrow-derived macrophages (BMMs) treated with granulocyte-macrophage colony-stimulating factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF), differentiate into GM-CSF-induced mouse bone marrow-derived macrophages (GM-BMMs) or M-CSF-induced mouse bone marrow-derived macrophages (M-BMMs), which have an M1 or M2 profile, respectively. GM-BMMs produce large amounts of proinflammatory cytokines and mediate resistance to pathogens, whereas M-BMMs produce antiinflammatory cytokines that contribute to tissue repair and remodeling. M-BMMs stimulated with lipopolysaccharide (LPS) are in an antiinflammatory state, with an IL-12(low) IL-10(high) phenotype. However, the regulation of this process remains unclear. Klf10 belongs to the family of Krüppel-like transcription factors and was initially described as a TGF-β inducible early gene 1. IL-12p40 is upregulated in LPS-stimulated M-BMMs from Klf10-deficient mice, but downregulated during Klf10 overexpression. Klf11, another member of the Krüppel-like factor family, can also repress the production of IL-12p40. Furthermore, Klf10 binds to the CACCC element of the IL-12p40 promoter and inhibits its transcription. We have therefore identified Klf10 as a transcription factor that regulates the expression of IL-12p40 in M-BMMs.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23065757 PMCID: PMC3842096 DOI: 10.1002/eji.201242697
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532